Showing results (101-110 of 581) with videos related to

Sort By:
Pageof 59
Human Pathology|October 6, 2015
Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumorNobuyoshi Takizawa, Yoshihiro Ohishi, Minako Hirahashi, et al.
Clinical Breast Cancer|March 13, 2018
Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast CancerNami Yamashita, Eriko Tokunaga, Makoto Iimori, et al.
European Radiology|August 6, 2015
Differentiation of early gastric cancer with ulceration and resectable advanced gastric cancer using multiphasic dynamic multidetector CTDaisuke Tsurumaru, Mitsutoshi Miyasaka, Yusuke Nishimuta, et al.
Nature Communications|April 1, 2016
Phosphorylation of EB2 by Aurora B and CDK1 ensures mitotic progression and genome stabilityMakoto Iimori, Sugiko Watanabe, Shinichi Kiyonari, et al.
Plos One|June 16, 2022
Impact of the suboptimal communication network environment on telerobotic surgery performance and surgeon fatigueHarue Akasaka, Kenichi Hakamada, Hajime Morohashi, et al.
Surgery Today|October 20, 2021
Social implementation of a remote surgery system in Japan: a field experiment using a newly developed surgical robot via a commercial networkHajime Morohashi, Kenichi Hakamada, Takahiro Kanno, et al.
Surgery Today|December 9, 2023
Effects of communication delay in the dual cockpit remote robotic surgery systemYoshiya Takahashi, Kenichi Hakamada, Hajime Morohashi, et al.
Cancer Science|April 1, 2022
CD44v3,8-10 is essential for Slug-dependent vimentin gene expression to acquire TGF-β1-induced tumor cell motilityShichao Qiu, Makoto Iimori, Keitaro Edahiro, et al.
International Journal of Cancer|October 19, 2017
Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instabilityShotaro Korehisa, Eiji Oki, Makoto Iimori, et al.
BMC Cancer|January 10, 2018
Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapyHiroshi Saeki, Yasunori Emi, Eiji Oki, et al.
Pageof 59